A Randomized Phase 1 Study Comparing The Safety and Oral Pharmacokinetics Of 0.25 mg and 1.0 mg Aminopterin Tablets In Human Subjects With Psoriasis.

Trial Profile

A Randomized Phase 1 Study Comparing The Safety and Oral Pharmacokinetics Of 0.25 mg and 1.0 mg Aminopterin Tablets In Human Subjects With Psoriasis.

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Nov 2012

At a glance

  • Drugs Aminopterin (Primary)
  • Indications Plaque psoriasis
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 27 Apr 2010 Actual end date (Apr 2010) added as reported by ClinicalTrials.gov.
    • 27 Apr 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 22 Oct 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top